Subcortical Ischemic Vascular Dementia: Assessment with Quantitative MR Imaging and ¹H MR Spectroscopy

References

1. ↵
   Roman GC. The epidemiology of vascular dementia. In: Hartmann A, Kuschinsky W, Hoyer S, eds. Cerebral Ischemia and Dementia. Berlin: Springer-Verlag, 1991: 9-15
2. Yamaguchi T, Ogata J, Yoshida F. Epidemiology of vascular dementia in Japan: Proceedings of the NINDS-AIREN International Workshop on Vascular Dementia. National Institutes of Health, Bethesda, MD, April 19–21, 1991
3. Suzuki K, Kutsuzawa T, Nakajinia K, Hatano S. Epidemiology of vascular dementia and stroke in Japan. In: Hartmann A, Kuschinsky W, Hoyer S, eds. Cerebral Ischemia and Dementia. Berlin: Springer-Verlag, 1991: 16-24
4. ↵
   Tomlinson BE, Henderson G. Some quantitative cerebral findings in normal and demented old people. In: Terry RD, Gershon S, eds. Neurobiology of Aging. New York: Raven Press, 1976
5. ↵
   Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF. Classification, diagnosis and treatment of vascular dementia. Drugs Aging 1997;11:361-373

   PubMedWeb of Science
6. ↵
   Roman GC, Tatemichi TK, Erkinjutti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260

   Abstract/FREE Full Text
7. ↵
   Miller Fischer C. Lacunes: small, deep cerebral infarcts. Neurology 1965;15:774-784

   FREE Full Text
8. ↵
   Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain 1988;111:1425-1439

   CrossRefPubMedWeb of Science
9. Roman GC. From UBOs to Binswanger's disease: impact of magnetic resonance imaging on vascular dementia research. Stroke 1996;27:1269-1273

   FREE Full Text
10. Caplan LR. Binswanger's disease-revisited. Neurology 1995;45:626-633

    FREE Full Text
11. ↵
    De Reuck JL. Evidence for chronic ischemia in the pathogenesis of vascular dementia: from neuroPATH to neuroPET. Acta Neurol Belg 1996;96:228-231

    PubMed
12. Risberg J, Gustafson L. Regional cerebral blood flow measurements in the clinical evaluation of demented patients. Dement Geriatr Cogn Disord 1997;8:92-97

    CrossRefPubMed
13. Mielke R, Kessler J, Szelies B, Herholz K, Wienhard K, Heiss W-D. Vascular dementia: perfusional and metabolic disturbances and effects of therapy. J Neural Transm 1996[suppl];47:183-191
14. ↵
    Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia: clinical and positron emission tomography findings. Arch Neurol 1995;52:773-780

    CrossRefPubMedWeb of Science
15. ↵
    De Reuck J, Decoo D, Marchau M, Santens P, Lemahieu I, Strijckmans K. Positron emission tomography in vascular dementia. J Neurol Sci 1998;154:55-61

    CrossRefPubMedWeb of Science
16. ↵
    Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996;27:408-414

    Abstract/FREE Full Text
17. Mochizuki Y, Oishi M, Takasu T. Cerebral blood flow in single and multiple lacunar infarctions. Stroke 1997;28:1458-1460

    Abstract/FREE Full Text
18. ↵
    Mielke R, Herholz K, Grond M, Kessler J, Heiss W-D. Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992;49:909-913

    CrossRefPubMedWeb of Science
19. ↵
    Hachinski VC, Potter P, Merskey H. Leuko-Araiosis. Arch Neurol 1987;44:21-23

    CrossRefPubMedWeb of Science
20. ↵
    Grafton ST, Sumi SM, Stimac GK, Alvord EC, Shaw C-M, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol 1991;48:293-298

    CrossRefPubMedWeb of Science
21. ↵
    Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology 1981;5:549-564

    CrossRefPubMedWeb of Science
22. ↵
    Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in ¹H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31

    CrossRefPubMedWeb of Science
23. ↵
    Meyerhoff DJ, MacKay S, Constans J-M, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40-47

    CrossRefPubMedWeb of Science
24. Constans JM, Meyerhoff DJ, Gerson J, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995;197:517-523

    CrossRefPubMedWeb of Science
25. ↵
    MacKay S, Meyerhoff DJ, Constans J-M, Norman D, Fein G, Weiner MW. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with ¹H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167-174

    CrossRefPubMedWeb of Science
26. ↵
    MacKay S, Ezekiel F, Di Sclafani V, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996;198:537-545

    CrossRefPubMedWeb of Science
27. ↵
    Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology 1997;49:1513-1521

    Abstract/FREE Full Text
28. Schuff N, Amend D, Meyerhoff D. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 1998;207:91-102

    PubMedWeb of Science
29. ↵
    Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437

    CrossRefPubMedWeb of Science
30. Tedeschi G, Bertolino A, Lundbom N, et al. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 1996;47:696-704

    Abstract/FREE Full Text
31. Kattapong VJ, Brooks WM, Wesley MH, Kodituwakku PW, Rosenberg GA. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia. Arch Neurol 1996;53:678-680

    CrossRefPubMedWeb of Science
32. Brooks WM, Wesley MH, Kodituwakku PW, Garry PJ, Rosenberg GA. ¹H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly. Stroke 1997;28:1940-1943

    Abstract/FREE Full Text
33. ↵
    Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease diagnostic and treatment centers. Neurology 1992;42:473-480

    Abstract/FREE Full Text
34. Jobst KA, Barnetson LPD, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Int Psychogeriatr 1997;9[suppl 1]::191-222
35. ↵
    McKann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944

    Abstract/FREE Full Text
36. ↵
    Haupt CI, Schuff N, Weiner MW, Maudsley AA. Lipid removal in 1H spectroscopic imaging by data extrapolation. Magn Reson Med 1996;35:678-687

    PubMedWeb of Science
37. ↵
    Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994;31:645-651

    CrossRefPubMedWeb of Science
38. ↵
    Haase A, Frahm J, Hänicke W, Matthaei D. ¹H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-344

    CrossRefPubMedWeb of Science
39. ↵
    Tanabe J, Amend D, Schuff N, et al. Tissue segmentation of the brain in Alzheimer's disease. Am J Neuroradiol 1997;18:115-123

    Abstract
40. ↵
    Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis. Magn Reson Imaging 1992;10:471-485

    CrossRefPubMedWeb of Science
41. ↵
    Lu D, Margouleff C, Rubin E. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med 1997;37:18-23

    PubMedWeb of Science
42. ↵
    Pappata S, Mazoyer B, Tran Dinh S, Cambon H, Levasseur M, Baron JC. Effects of capsular or thalamic stroke on metabolism in the cortex and cerebellum: a positron tomography study. Stroke 1990;21:519-524

    Abstract/FREE Full Text
43. ↵
    Fulham MJ, Dietz MJ, Duyn JH, Shih HH-L, Alger JR, Di Chiro G. Transsynaptic reduction in N-acetyl-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study. J Comput Assist Tomogr 1994;18:697-704

    PubMedWeb of Science
44. ↵
    Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med 1995;33:595-600

    CrossRefPubMedWeb of Science
45. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259

    CrossRefPubMedWeb of Science
46. ↵
    Jack CR, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188

    Abstract/FREE Full Text
47. Cummings JL. Vascular subcortical dementias: clinical aspects. Dementia 1994;5:177-180

    PubMedWeb of Science
48. ↵
    Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880

    CrossRefPubMedWeb of Science
49. ↵
    Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986;36:340-345

    Abstract/FREE Full Text
50. Mori E, Ishii K, Hashimoto M, Imamura T, Hirono N, Kitagaki H. The role of functional brain imaging in evaluation of vascular dementia. Presented at the 3rd International Conference on Harmonization of Dementia Drug Guideline, 1998
51. Chabriat H, Pappata S, Levasseur M, Fiorelli M, Tran Dinh S, Baron JC. Cortical metabolism in posterolateral thalamic stroke: PET study. Acta Neurol Scand 1992;86:285-290

    CrossRefPubMed
52. ↵
    Bondareff W, Raval J, Woo B, Hauser DL, Colletti PM. Magnetic resonance imaging and the severity of dementia in older adults. Arch Gen Psychiatry 1990;47:47-51

    CrossRefPubMedWeb of Science
53. Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-143

    Abstract/FREE Full Text
54. ↵
    Giubilei F, Bastianello S, Paolillo A, et al. Quantitative magnetic resonance analysis in vascular dementia. J Neurol 1997;244:246-251

    CrossRefPubMedWeb of Science
55. ↵
    Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995;13:457-462

    CrossRefPubMedWeb of Science
56. ↵
    Lim KO, Spielman DM. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 1997;37:372-377

    CrossRefPubMedWeb of Science
57. Hetherington HP, Pan JW, Mason GF, et al. Quantitative ¹H spectroscopic imaging of human brain at 4.1T using image segmentation. Magn Reson Med 1996;36:21-29

    CrossRefPubMedWeb of Science
58. Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn Reson Med 1995;33:755-759

    CrossRefPubMedWeb of Science
59. ↵
    Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998;40:822-831

    CrossRefPubMedWeb of Science